Update multiple endocrine neoplasia type 2
Raue F1, Frank-Raue K. Fam Cancer. 2010 Sep;9(3):449-57. doi: 10.1007/s10689-010-9320-2. https://www.ncbi.nlm.nih.gov/pubmed/20087666
Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
J. Moyes, J. P. Monson, S. L. Chew, S. A. Akker Int J Endocrinol. 2010; 2010: 906163. Published online 2010 May 26. doi: 10.1155/2010/906163 PMCID: PMC2877200 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877200/
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Ambrosini V1, Campana D, Bodei L, Nanni C, Castellucci P, Allegri V, Montini GC, Tomassetti P, Paganelli G, Fanti S. J Nucl Med. 2010 May;51(5):669-73. doi: 10.2967/jnumed.109.071712. https://www.ncbi.nlm.nih.gov/pubmed/20395323
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.
Appetecchia M1, Baldelli R. J Exp Clin Cancer Res. 2010 Mar 2;29:19. doi: 10.1186/1756-9966-29-19. https://www.ncbi.nlm.nih.gov/pubmed/20196864
Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.
Toledo SP1, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE. Clinics (Sao Paulo). 2009;64(7):699-706. doi: 10.1590/S1807-59322009000700015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710445/
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors.
Falchetti, F. Marini, E. Luzi, Giusti F, L. Cavalli, T. Cavalli, M. L. Brandi (2009). GENETICS IN MEDICINE, vol. 11; p. 825-835, ISSN: 1098-3600, doi: 0.1097/GIM.0b013e3181be5c97 https://www.ncbi.nlm.nih.gov/pubmed/19904212
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
L.Papi, D.Palli, L.Masi, A.L.Putignano, C.Congregati, I.Zanna, F. Marini, Giusti F, E.Luzi, F.Tonelli, M.Genuardi, M.L.Brandi, A.Falchetti (2009). CANCER GENETICS AND CYTOGENETICS, vol. 195(1); p. 75-79, ISSN: 0165-4608 https://www.ncbi.nlm.nih.gov/pubmed/19837273